Results 131 to 140 of about 20,556 (211)

Efficacy of 7-day Tailored Therapy for <i>Helicobacter pylori</i> Eradication based on Clarithromycin Resistance. [PDF]

Korean J Gastroenterol, 2023
Bae JH, Jo HH, Kwon JG, Kim EY.
europepmc   +1 more source

Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits

, 2010
Primary clarithromycin resistance is increasing worldwide, and it has been regarded as the main factor reducing the efficacy of Helicobacter pylori therapy.
Giorgio F, Perna, Francesco, Morini S, Zullo Ierardi E, Hassan C, De Francesco V, PERNA, FEDERICO, Hassan, Cesare, VAIRA, BERARDINO, Pannella C   +9 more
core   +1 more source

A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance. [PDF]

Intern Med, 2023
Adachi K, Kato S, Koshino A, Nagao K, Sugiyama T, Yoshimine T, Yamaguchi Y, Izawa S, Ohashi W, Ebi M, Funaki Y, Ogasawara N, Sasaki M, Kasugai K.   +13 more
europepmc   +1 more source

Current eradication rate of Helicobacter pylori with clarithromycin-based triple therapy in a gastroenterology practice in the New York metropolitan area

, 2018
Devjit S Nayar Gastroenterology Associates of Central Jersey, Edison, NJ, USA Background: In order to mitigate potential issues with antibiotic resistance in the treatment of patients with Helicobacter pylori infection, the selection of a therapeutic ...
Nayar DS
core  

Comparative molecular profiling of Helicobacter pylori infection and antibiotic genotypic resistance in paired gastric mucosa, gastric juice, and stool samples

Scientific Reports
Increasing antibiotic resistance in Helicobacter pylori (H. pylori) is undermining empirical eradication therapies. Non-invasive methods for resistance profiling are urgently needed to guide precision treatment.
Jianping Cheng, Chanjuan Fan, Xiaolin Zhao, Zhen Li, Dongling Xie, Yong Cai, Kun Huang, Mengyuan Yang, Hui Wang   +8 more
doaj   +1 more source

Efficacy of Phenotype-vs. Genotype-Guided Therapy Based on Clarithromycin Resistance for Helicobacter pylori Infection in Children. [PDF]

Front Pediatr, 2022
Feng Y, Hu W, Wang Y, Lu J, Zhang Y, Tang Z, Miao S, Zhou Y, Huang Y.   +8 more
europepmc   +1 more source

Effectiveness of 7-day triple therapy with half-dose clarithromycin for the eradication of Helicobacter pylori without the A2143G and A2142G point mutations of the 23S rRNA gene in a high clarithromycin resistance area. [PDF]

Front Med (Lausanne), 2023
Cho SH, Park MS, Park SY, Kim DH, You HS, Kim HS.   +5 more
europepmc   +1 more source

Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides. [PDF]

Nat Commun, 2021
Kocsmár É, Buzás GM, Szirtes I, Kocsmár I, Kramer Z, Szijártó A, Fadgyas-Freyler P, Szénás K, Rugge M, Fassan M, Kiss A, Schaff Z, Röst G, Lotz G.   +13 more
europepmc   +1 more source

Detection of clarithromycin resistance and 23SrRNA point mutations in clinical isolates of Helicobacter pylori isolates: Phenotypic and molecular methods. [PDF]

Saudi J Biol Sci, 2022
Hussein RA, Al-Ouqaili MTS, Majeed YH.
europepmc   +1 more source

Correlation between clarithromycin resistance, virulence factors and clinical characteristics of the disease in Helicobacter pylori infected patients in Shahrekord, Southwest Iran. [PDF]

AMB Express, 2021
Hosseini RS, Rahimian G, Shafigh MH, Validi M, Khaledi M, Gholipour A.   +5 more
europepmc   +1 more source